Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice

Endocrinology

Volumn 151, Issue 11, 2010, Pages 5174-5184

  Wilson, Camella G ^a   Schupp, Michael ^a   Burkhardt, Brant R ^b   Wu, Jianmei ^b   Young, Robert A ^b   Wolf, Bryan A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; ADENOVIRUS VECTOR; CORTICOSTERONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; DEXAMETHASONE; FORSKOLIN; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; PANCREATIC DERIVED FACTOR; SERINE; UNCLASSIFIED DRUG; CYCLIC AMP; PANDER PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; DIET RESTRICTION; GENE EXPRESSION; GENE TARGETING; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; INSULIN SENSITIVITY; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ADENOVIRUS; ANIMAL; BLOOD; CULTURE MEDIUM; GENETICS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LIVER; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CULTURE MEDIA, CONDITIONED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOKINES; FASTING; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HEPATOCYTES; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 78049511254     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0379     Document Type: Article

References (60)

1. Zhu Y, Xu G, Patel A, McLaughlin MM, Silverman C, Knecht K, Sweitzer S, Li X, McDonnell P, Mirabile R, Zimmerman D, Boyce R, Tierney LA, Hu E, Livi GP, Wolf B, Abdel-Meguid SS, Rose GD, Aurora R, Hensley P, Briggs M, Young PR 2002 Cloning, expression, and initial characterization of a novel cytokine-like gene family. Genomics 80:144-150
2. Cao X, Gao Z, Robert CE, Greene S, Xu G, Xu W, Bell E, Campbell D, Zhu Y, Young R, Trucco M, Markmann JF, Naji A, Wolf BA 2003 Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells. Diabetes 52:2296-2303
3. Yang J, Robert CE, Burkhardt BR, Young RA, Wu J, Gao Z, Wolf BA 2005 Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells. Diabetes 54:3217-3228
4. Burkhardt BR, Yang MC, Robert CE, Greene SR, McFadden KK, Yang J, Wu J, Gao Z, Wolf BA 2005 Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoter. Biochim Biophys Acta 1730:215-225
5. Carnegie JR, Robert-Cooperman CE, Wu J, Young RA, Wolf BA, Burkhardt BR 2010 Characterization of the expression, localization, and secretion of PANDER in α-cells. Mol Cell Endocrinol 325:36-45
6. Yang J, Wang C, Li J, Burkhardt BR, Robert-Cooperman CE, Wilson C, Gao Z, Wolf BA 2009 PANDER binds to the liver cell membrane and inhibits insulin signaling in HepG2 cells. FEBS Lett 583:3009-3015
7. Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI 1991 Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254:573-576
8. Kahn CR, Goldstein BJ 1989 Molecular defects in insulin action. Science 245:13
9. Satake S, Moore MC, Igawa K, Converse M, Farmer B, Neal DW, Cherrington AD 2002 Direct and indirect effects of insulin on glucose uptake and storage by the liver. Diabetes 51:1663-1671
10. Jiang G, Zhang BB 2003 Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284:E671-E678
11. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L 2009 Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 32:281-286
12. Leahy JL 2005 Pathogenesis of type 2 diabetes mellitus. Arch Med Res 36:197-209
13. West KM 1959 Response of the blood glucose to glucocorticoids in man; determination of the hyperglycemic potencies of glucocorticoids. Diabetes 8:22-28
14. Qi D, Rodrigues B 2007 Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab 292:E654-E667
15. Rangwala SM, Rich AS, Rhoades B, Shapiro JS, Obici S, Rossetti L, Lazar MA 2004 Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53:1937-1941
16. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y 1998 Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862
17. Pickup JC, Chusney GD, Thomas SM, Burt D 2000 Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci 67:291-300
18. Robert-Cooperman CE, Carnegie JR, Wilson CG, Yang J, Cook JR, Wu J, Young RA, Wolf BA, Burkhardt BR 21 June 2010 Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic β-cell function. Diabetes 10.2337/db09-1552
19. Robert CE, Wu J, Burkhardt BR, Wolf BA 2005 Transgenic mice overexpressing the novel islet specific cytokine, PANDER, exhibit glucose intolerance. Diabetes 54(Suppl 1):74-LB (Abstract)
20. Yang J, Gao Z, Robert CE, Burkhardt BR, Gaweska H, Wagner A, Wu J, Greene SR, Young RA, Wolf BA 2005 Structure-function studies of PANDER, an islet specific cytokine inducing cell death of insulin-secreting beta cells. Biochemistry 44:11342-11352
21. -ΔΔCT method. Methods 25:402-408
22. Herrmann J, Abriss B, van de Leur E, Weiskirchen S, Gressner AM, Weiskirchen R 2004 Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liver. Arch Virol 149:1611-1617
23. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM 2004 Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 114:224-231
24. Olefsky JM, Kimmerling G 1976 Effects of glucocorticoids on carbohydrate metabolism. Am J Med Sci 271:202-210
25. Perley M, Kipnis DM 1966 Effect of glucocorticoids on plasma insulin. N Engl J Med 274:1237-1241
26. GuC, Stein GH, Pan N, Goebbels S, Hörnberg H, Nave KA, Herrera P, White P, Kaestner KH, Sussel L, Lee JE 2010 Pancreatic β-cells require NeuroD to achieve and maintain functional maturity. Cell Metab 11:298-310
27. Ruderman NB 1975 Muscle amino acid metabolism and gluconeogenesis. Annu Rev Med 26:245-258
28. Klover PJ, Mooney RA 2004 Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol 36:753-758
29. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM 2001 Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138 (Pubitemid 32867868)
30. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B, Montminy M 2001 CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413:179-183 (Pubitemid 32867880)
31. Iynedjian PB, Auberger P, Guigoz Y, Le Cam A 1985 Pretranslational regulation of tyrosine aminotransferase and phosphoenolpyruvate carboxykinase (GTP) synthesis by glucagon and dexamethasone in adult rat hepatocytes. Biochem J 225:77-84
32. Cheng RY, Birely LA, Lum NL, Perella CM, Cherry JM, Bhat NK, Kasprzak KS, Powell DA, Alvord WG, Anderson LM 2004 Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis. J Mol Endocrinol 32:257-278
33. Angrand PO, Coffinier C, Weiss MC 1994 Response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids depends on the integrity of the cAMP pathway. Cell Growth Differ 5:957-966
34. O'Brien RM, Streeper RS, Ayala JE, Stadelmaier BT, Hornbuckle LA 2001 Insulin-regulated gene expression. Biochem Soc Trans 29:552-558
35. Schoneveld OJ, Gaemers IC, Lamers WH 2004 Mechanisms of glucocorticoid signalling. Biochim Biophys Acta 1680:114-128
36. Korach-André M, Gao J, Gounarides JS, Deacon R, Islam A, Laurent D 2005 Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance. Am J Physiol Endocrinol Metab 288:E106-116
37. Ai J, Wang N, Yang M, Du ZM, Zhang YC, Yang BF 2005 Development of Wistar rat model of insulin resistance. World J Gastroenterol 11:3675-3679
38. Stojanovska L, Rosella G, Proietto J 1990 Evolution of dexamethasone-induced insulin resistance in rats. Am J Physiol 258:E748-E756
39. Barzilai N, Rossetti L 1993 Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. J Biol Chem 268:25019-25025
40. Mayo KE, Miller LJ, Bataille D, Dalle S, Göke B, Thorens B, Drucker DJ 2003 International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55:167-194
41. Jelinek LJ, Lok S, Rosenberg GB, Smith RA, Grant FJ, Biggs S, Bensch PA, Kuijper JL, Sheppard PO, Sprecher CA, O'Hara PJ, Foster D, Walker KM, Chen LHJ, McKernan PA, Kindsvogel W 1993 Expression cloning and signaling properties of the rat glucagon receptor. Science 259:1614-1616
42. Gonzalez GA, Montminy MR 1989 Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675-680
43. Mayr B, Montminy M 2001 Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609
44. Erion DM, Ignatova ID, Yonemitsu S, Nagai Y, Chatterjee P, Weismann D, Hsiao JJ, Zhang D, Iwasaki T, Stark R, Flannery C, Kahn M, Carmean CM, Yu XX, Murray SF, Bhanot S, Monia BP, Cline GW, Samuel VT, Shulman GI 2009 Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. Cell Metab 10:499-506
45. Sasaki K, Cripe TP, Koch SR, Andreone TL, Petersen DD, Beale EG, Granner DK 1984 Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. J Biol Chem 259:15242-15251
46. Consoli A, Nurjhan N, Capani F, Gerich J 1989 Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38:550-557 (Pubitemid 19125601)
47. 13C nuclear magnetic resonance study. J Clin Invest 90:1323-1327
48. Carroll MF, Izard A, Riboni K, Burge MR, Schade DS 2002 Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia: implications for diabetes therapy. Diabetes Care 25:1247-1248
49. Edgerton DS, Jacobson PB, Opgenorth TJ, Zinker B, Beno D, von Geldern T, Ohman L, Scott M, Neal D, Cherrington AD 2006 Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production. Metabolism 55:1255-1262
50. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 67:1185-1248
51. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M, Montminy M 2003 cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev 17:1575-1580
52. Costes S, Vandewalle B, Tourrel-Cuzin C, Broca C, Linck N, Bertrand G, Kerr-Conte J, Portha B, Pattou F, Bockaert J, Dalle S 2009 Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in β-cells and human pancreatic islets. Diabetes 58:1105-1115
53. Inada A, Hamamoto Y, Tsuura Y, Miyazaki J, Toyokuni S, Ihara Y, Nagai K, Yamada Y, Bonner-Weir S, Seino Y 2004 Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes andcell proliferation in pancreatic β-cells. Mol Cell Biol 24:2831-2841
54. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, Kenyon CJ, Walker BR 2000 Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141:560-563
55. Jacobson PB, von Geldern TW, Ohman L, Osterland M, Wang J, Zinker B, Wilcox D, Nguyen PT, Mika A, Fung S, Fey T, Goos-Nilsson A, Grynfarb M, Barkhem T, Marsh K, Beno DW, Nga- Nguyen B, Kym PR, Link JT, Tu N, Edgerton DS, Cherrington A, Efendic S, Lane BC, Opgenorth TJ 2005 Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes. J Pharmacol Exp Ther 314:191-200
56. Karpac J, Czyzewska K, Kern A, Brush RS, Anderson RE, Hochgeschwender U 2008 Failure of adrenal corticosterone production in POMC-deficient mice results from lack of integrated effects of POMC peptides on multiple factors. Am J Physiol Endocrinol Metab 295:E446-E455
57. Lo MJ, Wang PS 2002 Involvement of cAMP but not PKA in the increase of corticosterone secretion in rat zona fasciculata-reticularis cells by aging. J Cell Biochem 85:35-41
58. Rodbard D 1974 Apparent positive cooperative effects in cyclic AMP and corticosterone production by isolated adrenal cells in response to ACTH analogues. Endocrinology 94:1427-1437
59. Friedman TC, Mastorakos G, Newman TD, Mullen NM, Horton EG, Costello R, Papadopoulos NM, Chrousos GP 1996 Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. Endocr J 43:645-655
60. Karatsoreos IN, Bhagat SM, Bowles NP, Weil ZM, Pfaff DW, McEwen BS 2010 Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology 151:2117-2127